CARISA - Ranolanzine CVT 3033
- 648 participants
- 6 sites in New Zealand
Combination Assessment of Ranolazine In Stable Angina. A double-blind, randomized, stratified, placebo-controlled, parallel study of Ranolazine SR at doses of 750mg twice a day and 1000mg twice a day in combination with other anti-anginal medications in 648 patients with Chronic stable angina pectoris.